Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:00 PM
Ignite Modification Date:
2025-12-24 @ 5:00 PM
NCT ID:
NCT05152550
Eligibility Criteria:
Inclusion Criteria:
1. Gestational age above 20 weeks of gestation.
2. Cases diagnosed as Non-severe pre-eclampsia after exclusion of severity features which include:
* Systolic blood pressure ≥160 mmHg or diastolic blood pressure ≥110 mmHg.
* Symptoms of central nervous system dysfunction of new onset such as Photopsia, scotomata, cortical blindness, retinal vasospasm, and severe headache.
* Hepatic abnormality: Severe persistent right upper quadrant or Epigastric pain or serum transaminase concentration ≥2 times the upper limit of the normal range, or both.
* Thrombocytopenia: \< 100,000 platelets/µL.
* Pulmonary edema.
Exclusion Criteria:
1. Vesicular mole (complete or incomplete).
2. Any cause of Albuminuria rather than PET such as (chronic kidney disease, type1 Diabetes mellitus.)
3. Any liver disease (Acute liver diseases cause increased liver transaminases and chronic liver diseases cause decreased production of albumin and transaminases.)
4. Any autoimmune disease that affects blood vessels or PLT count such as (ITP, TTP, SLE and rheumatoid arthritis.)
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
20 Years
Maximum Age:
40 Years
Study:
NCT05152550
Study Brief:
Protocol Section:
NCT05152550